ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,451Medicare Part D Prescriptions Filled, Including Refills

Rank: 269 out of 1454

$552K Total Retail Price of All Prescriptions

Rank: 369 out of 1454

400 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 400 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

11% of this provider’s 400 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 9,949 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
SIMVASTATIN 550 484 1 1
AMLODIPINE BESYLATE 451 412 2 2
LISINOPRIL 381 368 3 4
HYDROCODONE-ACETAMINOPHEN 367 242 S3 4 7
ATORVASTATIN CALCIUM 329 300 5 11
METFORMIN HCL 304 267 6 8
LEVOTHYROXINE SODIUM 298 264 7 5
PRAVASTATIN SODIUM 254 239 8 12
METOPROLOL TARTRATE 249 228 9 10
HYDROCHLOROTHIAZIDE 247 227 10 9
OMEPRAZOLE 223 170 11 3
METOPROLOL SUCCINATE 195 182 12 13
ATENOLOL 186 175 13 18
SYNTHROID 184 171 14 25
SERTRALINE HCL 172 162 15 26
FUROSEMIDE 163 139 16 6
CARVEDILOL 154 113 17 24
GLIMEPIRIDE 135 126 18 33
NEXIUM 132 110 19 23
POTASSIUM CHLORIDE 130 129 20 15
BENAZEPRIL HCL 128 124 21 57
MELOXICAM 126 96 22 37
GABAPENTIN 113 95 23 16
DONEPEZIL HCL 100 100 24 29
ISOSORBIDE MONONITRATE ER 98 84 25 46
QUINAPRIL HCL 86 86 26 101
ENALAPRIL MALEATE 81 81 27 58
TAMSULOSIN HCL 81 80 27 34
AZITHROMYCIN 80 65 29 42
TRAMADOL HCL 80 61 29 20
WARFARIN SODIUM 77 70 31 17
METFORMIN HCL ER 73 73 32 41
LISINOPRIL-HYDROCHLOROTHIAZIDE 72 72 33 27
GLIPIZIDE 71 59 34 62
FLUTICASONE PROPIONATE 70 65 35 30
LOSARTAN-HYDROCHLOROTHIAZIDE 69 55 36 38
ALLOPURINOL 68 58 37 28
ADVAIR DISKUS 68 64 37 47
CIPROFLOXACIN HCL 67 63 39 64
CELEBREX 66 61 40 81
ALENDRONATE SODIUM 66 66 40 35
TRIAMTERENE-HCTZ 65 65 42 44
DIOVAN 65 65 42 40
OXYCODONE-ACETAMINOPHEN 65 47 S2 42 60
LEVOXYL 63 63 45 84
FLUOXETINE HCL 63 43 45 72
CITALOPRAM HBR 62 52 47 21
CLOPIDOGREL 61 56 48 32
ZOLPIDEM TARTRATE 61 58 48 19
DILTIAZEM ER 60 60 50 126
LOVASTATIN 59 56 51 39
PLAVIX 54 51 52 45
CARISOPRODOL 54 28 R 52 123
SPIRIVA 54 54 52 52
LANTUS 54 50 52 51
LIPITOR 53 49 56 74
GLIPIZIDE XL 52 50 57 85
DOXAZOSIN MESYLATE 52 52 57 87
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.